Related Experiment Video
Updated: Nov 10, 2025
07:14
A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
Published on: January 18, 2018
9.5K
Alleviating Terminal Pediatric Cancer Pain
Karen Moody1, Mohammad Baig1, Veronica Carullo2
1Department of Pediatrics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Children (Basel, Switzerland)
|April 3, 2021
Summary
Managing end-of-life cancer pain in children is crucial. This guide offers a practical, step-by-step approach to effectively alleviate pediatric terminal cancer pain in various settings.
Area of Science:
- Pediatric Oncology
- Palliative Care
- Pain Management
Background:
- Terminal cancer pain is a significant challenge in pediatric oncology.
- Effective pain management is essential for end-of-life care in children with cancer.
- Most end-of-life pain in these patients can be successfully managed.
Purpose of the Study:
- To present a practical, step-by-step approach for alleviating pediatric terminal cancer pain.
- To provide guidance for healthcare professionals managing end-of-life cancer pain in children.
- To offer a framework for pain management that is applicable across different care settings.
Main Methods:
- Review of current best practices in pediatric palliative care.
- Step-by-step clinical guidelines for opioid use in end-of-life cancer pain.
- Adaptation of pain management strategies for diverse healthcare environments.
Main Results:
- Opioids are the primary pharmacologic agents for managing end-of-life cancer pain in children.
- A structured, step-by-step approach can lead to successful pain alleviation.
- The proposed methods are adaptable to various clinical settings, including home care and hospice.
Conclusions:
- Pediatric terminal cancer pain can be effectively managed with a systematic approach.
- Opioid therapy, when applied correctly, is a cornerstone of successful end-of-life pain control.
- This practical guide facilitates consistent and compassionate care for children with terminal cancer pain.
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
484
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
484
01:25Analgesia and Pain Management
1.1K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.1K
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
632
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
632
01:23Peripheral Artery Disease V: Postoperative Nursing Management
102
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
102
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
342
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
342
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K